Nasdaq: AMGN
Amgen Inc. (AMGN)
Amgen Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker AMGN. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.
Key facts
- Ticker symbol
- AMGN
- Exchange
- Nasdaq
- SEC CIK
- 318154
- Official filings
- SEC EDGAR
Research AMGN
- Profile — Business description, headquarters, subsidiaries and corporate identifiers.
- Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
- SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
- Stock Analysis — Price chart, returns, technical indicators and related companies.
- News — Latest headlines and press coverage.
- Material Contracts — Material agreements filed as exhibits to SEC reports.
- Benchmark — Stock performance against the S&P 500, Nasdaq and economic indicators.
- Peer Comparison — Side-by-side financial ratios against industry peers.
Frequently asked questions
What is Amgen Inc.'s stock ticker?
Amgen Inc. trades under the ticker symbol AMGN on Nasdaq. Its SEC Central Index Key (CIK) is 318154.
Where can I read Amgen Inc.'s SEC filings?
The AMGN SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Amgen Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.
How can I analyze AMGN's financial statements?
The AMGN Financials page shows Amgen Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.
How does AMGN compare with its peers and the market?
The AMGN Peer Comparison page lines Amgen Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500 and Nasdaq.
For information only — not investment advice.